Autophagy inhibition potentiates the anti-angiogenic property of multikinase inhibitor anlotinib through JAK2/STAT3/VEGFA signaling in non-small cell lung cancer cells

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, February 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

reddit: 1 Redditor

Citations

dimensions_citation: 113 Dimensions

Readers on

mendeley: 54 Mendeley

Summary X Reddit Dimensions citations

So far, Dimensions has found 113 publications that cite this research output.

113

The most recent citing publications are shown below. View all 113 publications that cite this research output on Dimensions.

Efficiency of radiotherapy plus Anlotinib in alleviating edema and increasing radiosensitivity in symptomatic brain metastasis patients: A retrospective study

Preprint in Research Square (April 2024)

FOXM1 promotes the progression of non-small cell lung cancer by inhibiting miR-509-5p expression via binding to the miR-509-5p promoter region

Article in Heliyon (February 2024)

Synergistic effects of anlotinib and DDP synergy in breast cancer treatment: inhibiting of cell growth and migration, and augmenting apoptosis and autophagy via modulation of the VEGF/JAK2/STAT3 axis

Preprint in Research Square (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.